Trump Press Conference Ends Abruptly After Man Collapses During Live Broadcast in Oval Office

A White House press event led by U.S. President Donald Trump was suddenly halted on Thursday after a man collapsed during a live broadcast in the Oval Office.

The incident occurred while Eli Lilly CEO Dave Ricks was speaking beside the president during a policy announcement focused on reducing the cost of weight loss drugs. In a dramatic moment caught on camera, the man standing nearby appeared to lose balance before collapsing to the floor. Dr. Mehmet Oz — the former television host and now head of the Centers for Medicare and Medicaid Services — quickly rushed forward to assist the man, preventing him from hitting the ground. Several attendees moved to help as White House staff directed members of the press to exit the room. Moments later, White House Press Secretary, Karoline Leavitt addressed reporters, confirming that the unidentified man had fainted but was in stable condition. The White House Medical Unit acted immediately, and the gentleman is okay,” Leavitt said. “The press conference will resume shortly. After a brief pause, the event resumed without the man present. President Trump reassured viewers that the situation was under control One of the representatives got light-headed, but he’s fine,” Trump said. “We had a little interruption—sorry for that. Initial reports from Getty Images identified the man as Gordon Findlay, Novo Nordisk’s global brand director, but the company later denied that he attended the event. The individual’s identity has not yet been officially confirmed. Eli Lilly later thanked the White House medical team for their swift response, noting that the man had “fully recovered” after receiving immediate attention. The episode marks the second health-related scare linked to Dr. Oz in recent months. In April, his 11-year-old granddaughter, Philomena, fainted during his swearing-in ceremony in the Oval Office while President Trump delivered remarks. Her mother, Daphne Oz, later assured the public that Philomena had made a full recovery. Thursday’s event, which focused on lowering drug costs and expanding access to GLP-1 weight loss medications, resumed after the brief disruption, with President Trump and health industry executives continuing their discussions on healthcare affordability.